Your browser doesn't support javascript.
loading
Cardiometabolic disease, cognitive decline, and brain structure in middle and older age.
Dove, Abigail; Guo, Jie; Wang, Jiao; Vetrano, Davide Liborio; Sakakibara, Sakura; Laukka, Erika J; Bennett, David A; Xu, Weili.
Afiliación
  • Dove A; Aging Research Center Department of Neurobiology Care Sciences and Society Karolinska Institutet Stockholm Sweden.
  • Guo J; Aging Research Center Department of Neurobiology Care Sciences and Society Karolinska Institutet Stockholm Sweden.
  • Wang J; Department of Epidemiology and Biostatistics School of Public Health Tianjin Medical University Tianjin China.
  • Vetrano DL; Aging Research Center Department of Neurobiology Care Sciences and Society Karolinska Institutet Stockholm Sweden.
  • Sakakibara S; Stockholm Gerontology Research Center Stockholm Sweden.
  • Laukka EJ; Aging Research Center Department of Neurobiology Care Sciences and Society Karolinska Institutet Stockholm Sweden.
  • Bennett DA; Aging Research Center Department of Neurobiology Care Sciences and Society Karolinska Institutet Stockholm Sweden.
  • Xu W; Stockholm Gerontology Research Center Stockholm Sweden.
Alzheimers Dement (Amst) ; 16(2): e12566, 2024.
Article en En | MEDLINE | ID: mdl-38595913
ABSTRACT

INTRODUCTION:

The presence of multiple cardiometabolic diseases (CMDs) has been linked to increased dementia risk, but the combined influence of CMDs on cognition and brain structure across the life course is unclear.

METHODS:

In the UK Biobank, 46,562 dementia-free participants completed a cognitive test battery at baseline and a follow-up visit 9 years later, at which point 39,306 also underwent brain magnetic resonance imaging. CMDs (diabetes, heart disease, and stroke) were ascertained from medical records. Data were analyzed using age-stratified (middle age [< 60] versus older [≥ 60]) mixed-effects models and linear regression.

RESULTS:

A higher number of CMDs was associated with significantly steeper global cognitive decline in older (ß = -0.008; 95% confidence interval -0.012, -0.005) but not middle age. Additionally, the presence of multiple CMDs was related to smaller total brain volume, gray matter volume, white matter volume, and hippocampal volume and larger white matter hyperintensity volume, even in middle age.

DISCUSSION:

CMDs are associated with cognitive decline in older age and poorer brain structural health beginning already in middle age. Highlights We explored the association of CMDs with cognitive decline and brain MRI measures.CMDs accelerated cognitive decline in older (≥60y) but not middle (<60) age.CMDs were associated with poorer brain MRI parameters in both middle and older age.Results highlight the connection between CMDs and cognitive/brain aging.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Año: 2024 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Alzheimers Dement (Amst) Año: 2024 Tipo del documento: Article